ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB)

Clinical trial NCT07741461 · RECRUITING

Trial details

NCT number: NCT07741461
Sponsor: Xiamen Amoytop Biotech Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepaititis B

Start date: 2026-08-06
Primary completion: 2027-03-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.